Igc Pharma Inc

CUSIP 45408X308COM NEWIGCQ4 2025

Igc Pharma Inc — Owners — 13D/13G Beneficial Ownership · FBInvestor

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

18.3%

Max % of class reported

Institutional Holders

13F filers (latest quarter)

2 filings · latest Aug 14, 2024

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	Aug 14, 2024	Bradbury Strategic Investment Fund A (Cayman Islands Registration No. Cr-359857)	13D/A	18.3%	13.82M	SEC
2	May 21, 2024	Bradbury Strategic Investment Fund A (Cayman Islands Registration No. Cr-359857)	13D	18.3%	13.82M	SEC

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Vanguard Group Inc	1.15M	$322.9K
2	Renaissance Technologies LLC	919.6K	$258.8K
3	Geode Capital Management, LLC	860.5K	$242.2K
4	Blackrock, Inc.	703.8K	$198.0K
5	Citadel Advisors LLC	277.6K	$78.1K
6	State Street Corp	200.8K	$56.5K
7	Susquehanna International Group, LLP	155.0K	$43.6K
8	Northern Trust Corp	113.4K	$31.9K
9